The syndrome of amniotic fluid embolism: A potential contribution of bradykinin
Authors:
- France GauvinFGFrance Gauvin
- Giuseppe MolinaroGMGiuseppe Molinaro
- Line LeducLLLine Leduc
- Albert AdamAAAlbert Adam
- Georges E. RivardGRGeorges E. Rivard
- 1 October 2005
- journal article
- case report
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (4) , 1508-1512
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Biochemical Basis of Angioedema Associated With Recombinant Tissue Plasminogen Activator TreatmentStroke, 2002
- The Tissue Factor Pathway in Disseminated Intravascular CoagulationSeminars in Thrombosis and Hemostasis, 2001
- Administration of autologous fetal membranes: Effects on the coagulation in pregnant mini-pigsPediatric Critical Care Medicine, 2000
- Activation of the Plasma Kallikrein / Kinin System on Endothelial CellsProceedings of the Association of American Physicians, 1999
- Bradykinin receptorsGeneral Pharmacology: The Vascular System, 1997
- Amniotic fluid embolism: Analysis of the national registryAmerican Journal of Obstetrics and Gynecology, 1995
- Plasmin-Mediated Activation of Contact System in Response to Pharmacological ThrombolysisCirculation, 1995
- Quantification of des-Arg9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activationJournal of Immunological Methods, 1995
- Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissuesPeptides, 1994
- An ultrasensitive chemiluminoenzyme immunoassay for the quantification of human tissue kininogens: application to synovial membrane and cartilageJournal of Immunological Methods, 1994